Game changer? Cognitive-motor effects of VR exergaming compared to video-based training.

Ann MedAug 31, 2026 (epub)
Clinical ResearchPhysical Medicine & RehabilitationOpen access

Mona Herden, Sidney Grosprêtre, Pauline Eon et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial examined the cognitive and cognitive-motor effects of virtual reality (VR) exergaming compared to a non-immersive stick-fight video (SFV) in 55 healthy adults. Results indicated that VR training led to significant improvements in executive function, particularly in Stroop tasks and the Trail Making Test, with VR showing greater gains in cognitive-motor performance on specific tasks.

Key findings

  • VR training improved Stroop reading and inhibition with F(1,53) = 14.84 and F(1,53) = 10.99, respectively.
  • A significant time×group interaction for the Trail Making Test indicated greater changes following VR training (F(1,53) = 6.55).
  • Both groups improved cognitive-motor performance, but VR showed greater gains in the Fitts task (p = .006).

Why it matters

Understanding the differential effects of VR exergaming versus traditional video-based training can inform rehabilitation strategies aimed at enhancing cognitive and motor functions in various populations, potentially leading to more effective therapeutic interventions.

Source

PubMed · PMID 42670747Free full text on PubMed Central

Published in Ann Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Physical Medicine & Rehabilitation

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.